Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease

NCT02167256 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02167256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02167256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2014
Completion date
February 27, 2018
Enrollment
159 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease